search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Outsourcing Outsourcing


therapies


The last step in the production of a drug is fi ll/ fi nish. But while that term may evoke simple images of pills being decanted into containers, the reality can be much more complex, with


certain products needing a different approach to sterilisation before they can be sealed in packaging. David Callaghan speaks to Dalip Sethi, scientifi c affairs director at Terumo Blood and Cell Technologies, and Tom Heathman, vice president of commercial operations at Ori Biotech, to learn about the risks inherent in this fi nal step before drugs can be shipped.


Living


he fill/ finish stage of safe drug production often presents a unique set of challenges. In order to ensure each drug is proofed against any contamination, there are some essential questions the CDMO must answer: is a first stage terminal sterilisation procedure adequate? Or is an aseptic regime needed? And, if so, can the increased risk be contained? For drugs that are administered parenterally and through the ophthalmic route, as well as those that are inhaled or inserted into the ear, intense sterilisation is always a must. Terminal sterilisation techniques are usually enough for IV solutions such as saline, but aseptic methods are required for antibiotics, vaccines and biologics. If the drugs cannot cope with heat treatment at the conclusion of the process to secure a sterile outcome, then aseptic processing starts to become necessary.


T 20 World Pharmaceutical Frontiers / www.worldpharmaceuticals.net orld Pharmaceutical Frontiers / www.worldpharmaceuticals.net


Corona Borealis Studio/www.shutterstock.com


Corona Borealis Studio/www.shutterstock.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53